essence semaglutide The ACCP Endocrine and Metabolism PRN is wishing everyone a lovely holiday season 🎄✨ In your down time, here's a quick journal club review of the trial evaluating once-weekly 2.4 Phase 3 ESSENCE Trial: Semaglutide

Participants taking the highest dose (12mg) lost just over 24% of their body weight in 48 weeks, and 26% of participants lost at least 30% of their initial weight

Compounded semaglutide can also be effective, but results vary due to inconsistencies in preparation and dosing

Frequently Asked Troubleshooting Questions Why does my dose volume seem too small

Most side effects peak during dose increases and improve as your body adjusts

This includes: Rybelsus Interaction with Blood Pressure Drugs Amlodipine Lisinopril Losartan Hydrochlorothiazide Rybelsus Interaction with Diabetes Medications Metformin Jardiance (empagliflozin) Farxiga (dapagliflozin) Mounjaro (tirzepatide) Rybelsus Interaction with Thyroid Hormone Levothyroxine Rybelsus Interaction with Other Medications Atorvastatin Ibuprofen Duloxetine Omeprazole Rosuvastatin Disease Interactions Suicidal behavior and ideation Thyroid cancer GI adverse events Hypoglycemia Pancreatitis Retinopathy Alternatives If Rybelsus (semaglutide) is not suitable or available for you, your healthcare provider may consider these Rybelsus alternatives: Ozempic (semaglutide) a once-weekly GLP-1 injection for type 2 diabetes, also approved to reduce cardiovascular risk in certain adults